Skoči na glavni sadržaj

Izlaganje sa skupa

PREGNANCY AND ATYPICAL ANTIPSYCHOTICS

Klementina Ružić ; University Psychiatric Clinic Rijeka, Clinical Hospital Centre Rijeka, Croatia
Elizabeta Dadić-Hero ; Community Primary Health Centre, Primorsko-goranska county, Croatia
Rajna Knez ; University Psychiatric Clinic Rijeka, Clinical Hospital Centre Rijeka, Croatia
Paola Medved ; University of Derby, Derby, United Kingdom
Daniela Petrić ; University Psychiatric Clinic Rijeka, Clinical Hospital Centre Rijeka, Croatia


Puni tekst: engleski pdf 227 Kb

str. 368-370

preuzimanja: 931

citiraj


Sažetak

Scientific research aiming at discovering new generations of effective
medications is a common practice in medicine, and psychiatric research is no exception. Antipsychotics are used to treat chronic mental illnesses such as schizophrenia. The new generation of antipsychotics (atypicals) gradually reveal their advantages in comparison to the older generation of antipsychotics (conventional, typicals) and are increasingly applied to the everyday practice.
Although there are no differences in the therapeutic effectiveness between the two groups mentioned, atypical antipsychotics have become the drugs of choice.
A certain number of women in their reproductive age suffer from schizophrenia and other mental illnesses which demand antipsychotic treatment. Atypical antipsychotics have been available on the market since the mid 90’s so the experience in the application of these medicaments in treating pregnant women is relatively modest.
This study will present our own experience in the treatment of a pregnant woman suffering from schizophrenia, who was treated with ziprasidone for the duration of her pregnancy. The psychotic symptoms remained in remission throughout the whole pregnancy period, during labour and after the birth. The pregnancy course
remained normal all through to the birth, which was carried out naturally and normally. A healthy baby was born within the term expected.

Ključne riječi

paranoid schizophrenia; pregnancy; ziprasidone

Hrčak ID:

49226

URI

https://hrcak.srce.hr/49226

Datum izdavanja:

25.6.2009.

Posjeta: 1.483 *